U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07247734) titled 'The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation' on Sept. 29.
Brief Summary: The aim for this clinical trial is to evaluate if colchicine in addition to standard of care improves insulin sensitivity in individuals with type 1 diabetes, systemic low-grade inflammaiton and reduced insulin sensitivity. The insulin sensitivity will be evaluated by a hyperinsulinemic, euglycemic clamp.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes
Chronic Inflammation
Insulin Sensitivity
Intervention:
DRUG: Colchicin 0.5 mg once daily for two ...